Global Pain Management Drugs Market
Trend & Growth Rate Report
Pain management drugs are defined as specific drug classes that have pharmacological actions on pain
receptors & work against the pain symptoms. These drugs can be used for pain management of
conditions, as indicated on label & some drugs have off-label uses. For example, antidepressants &
anticonvulsants were originally used for the management of depression & epilepsy respectively.
However, these drugs have shown activity against pain indications & are prescribed for pain
management as off-label indication.
Growing geriatric population is the main factor which drives global pain management drugs market
growth, as geriatric people are more to suffer from joint as well as other chronic conditions.
Get Sample Copy of this Report @ https://qualiketresearch.com/request-sample/Pain-
In the report, Global Pain Management Drugs Market has been analyzed through
a segmental perspective. The market segmentation allows a deeper
understanding of the market hotspots.
Also, the increase in prevalence of chronic diseases like diabetes, cancer, and osteoarthritis will
positively influence the market growth. In addition, the increase in number of surgical procedures and
growing healthcare expenditure are expected to propel the global pain management drugs market
Furthermore, lack of alternative treatment therapies is expected to boost the target market growth
throughout the forecast period. For instance, in 2015, Depomed, Inc. has acquired the United States
rights to NUCYNTA ER (tapentadol), NUCYNTA (tapentadol), extended-release tablets & NUCYNTA
(tapentadol) oral solution from Janssen Pharmaceuticals, Tapentadol is available in solution, tablet,
and extended-release forms. Moreover, the solution & tablet forms of NUCYNTA have three patents,
out of which one expired in the June 2017 and remaining two will expire in June 2025 & August 2029,
respectively. Moreover, patent e